Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein
1997

Indomethacin Reverses Drug Resistance in Cancer Cells

publication Evidence: moderate

Author Information

Author(s): MP Draper, RL Martell, SB Levy

Primary Institution: Tufts University School of Medicine

Hypothesis

Can indomethacin modulate multidrug resistance in cancer cells overexpressing MRP?

Conclusion

Indomethacin increases drug accumulation and sensitivity in MRP-overexpressing cancer cells.

Supporting Evidence

  • Indomethacin increased BCECF accumulation in MRP-expressing cell lines.
  • Indomethacin did not affect P-glycoprotein-mediated drug export.
  • Indomethacin enhanced sensitivity to vincristine and doxorubicin in resistant cell lines.

Takeaway

Indomethacin is a medicine that helps some cancer cells take in more drugs, making them more sensitive to treatment.

Methodology

The study involved cell culture, fluorescence measurements, and drug susceptibility assays using MTT.

Limitations

The specific mechanism of indomethacin's action on MRP remains unclear.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication